EAM Investors LLC acquired a new stake in Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) in the third quarter, according to its most recent filing with the SEC. The fund acquired 146,992 shares of the company’s stock, valued at approximately $3,931,000. EAM Investors LLC owned approximately 0.82% of Tabula Rasa Healthcare at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. TIAA CREF Investment Management LLC grew its stake in Tabula Rasa Healthcare by 108.5% in the 1st quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock valued at $110,000 after buying an additional 4,232 shares in the last quarter. New York State Common Retirement Fund grew its position in shares of Tabula Rasa Healthcare by 257.0% during the 2nd quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock valued at $151,000 after purchasing an additional 7,199 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Tabula Rasa Healthcare during the 1st quarter valued at $178,000. Cadence Capital Management LLC purchased a new position in shares of Tabula Rasa Healthcare during the 2nd quarter valued at $210,000. Finally, Financial Consulate Inc. purchased a new position in shares of Tabula Rasa Healthcare during the 3rd quarter valued at $222,000. Institutional investors and hedge funds own 28.41% of the company’s stock.

TRHC has been the subject of a number of recent analyst reports. Piper Jaffray Companies restated a “buy” rating and set a $29.00 price target on shares of Tabula Rasa Healthcare in a research report on Tuesday, October 24th. First Analysis initiated coverage on shares of Tabula Rasa Healthcare in a research report on Wednesday, November 1st. They set an “overweight” rating and a $41.00 price target for the company. Robert W. Baird restated an “outperform” rating and set a $30.00 price target (up from $22.00) on shares of Tabula Rasa Healthcare in a research report on Tuesday, October 17th. UBS AG boosted their price target on shares of Tabula Rasa Healthcare from $18.00 to $25.00 and gave the company a “buy” rating in a research report on Wednesday, August 30th. Finally, Wells Fargo & Company lowered shares of Tabula Rasa Healthcare from an “outperform” rating to a “market perform” rating and boosted their price target for the company from $17.00 to $21.00 in a research report on Thursday, September 7th. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $28.25.

In other news, insider Orsula V. Knowlton sold 8,000 shares of Tabula Rasa Healthcare stock in a transaction on Wednesday, October 18th. The shares were sold at an average price of $26.68, for a total transaction of $213,440.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 45.80% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “EAM Investors LLC Takes $3.93 Million Position in Tabula Rasa Healthcare Inc. (TRHC)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/21/eam-investors-llc-takes-3-93-million-position-in-tabula-rasa-healthcare-inc-trhc.html.

Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) remained flat at $$34.54 during midday trading on Tuesday. The company’s stock had a trading volume of 203,600 shares, compared to its average volume of 91,660. Tabula Rasa Healthcare Inc. has a one year low of $10.95 and a one year high of $35.70. The company has a current ratio of 0.73, a quick ratio of 0.66 and a debt-to-equity ratio of 0.47.

Tabula Rasa Healthcare (NASDAQ:TRHC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.02. Tabula Rasa Healthcare had a negative net margin of 2.27% and a negative return on equity of 5.58%. The company had revenue of $33.27 million during the quarter, compared to the consensus estimate of $31.76 million. During the same period in the previous year, the firm posted $0.06 EPS. The firm’s revenue was up 37.6% compared to the same quarter last year. research analysts predict that Tabula Rasa Healthcare Inc. will post 0.05 earnings per share for the current fiscal year.

About Tabula Rasa Healthcare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa Healthcare Inc. (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa Healthcare (NASDAQ:TRHC)

Receive News & Stock Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related stocks with our FREE daily email newsletter.